ASH 2012 Multiple Myeloma Update – Day Two: Early Afternoon Oral Session
This year’s American Society of Hematology (ASH) annual meeting, which is being held in Atlanta, began yesterday and goes through Tuesday. Today’s myeloma-related presentations began this afternoon...
View ArticleASH 2012 Multiple Myeloma Update – Day Two: Late Afternoon Oral Session
Yesterday was the second day of the 2012 American Society of Hematology (ASH) annual meeting, which is being held in Atlanta. The day’s myeloma-related presentations began in the afternoon with three...
View ArticleCircularly Permuted TRAIL May Be Effective For Relapsed/Refractory Multiple...
Results from three Chinese clinical trials indicate that the investigational drug circularly permuted TRAIL may be effective alone or in combination with thalidomide in relapsed and refractory multiple...
View ArticleBeacon NewsFlashes – December 19, 2012
Fewer Injection Site Reactions With Subcutaneous Velcade Administered To The Abdomen Instead Of The Thigh - Japanese researchers recently found that subcutaneous (under the skin) injections of Velcade...
View ArticleMultiple Myeloma And The ASH 2012 Meeting: Taking Stock And Tagging The...
This year’s meeting of the American Society of Hematology (ASH) was held December 8 through 11 in Atlanta. During the meeting, The Beacon published daily updates that provided overviews of the...
View ArticleAdvanced Age And Organ Damage Associated With Poor Survival In Elderly...
A team of European researchers recently found that advanced age, kidney failure, infections, heart and gastrointestinal complications, and drug discontinuation are associated with poor survival among...
View ArticleUpdate Presented About Cereblon And Resistance To Pomalyst, Revlimid, And...
During a session at the International Myeloma Workshop (IMW) held in Japan last week, Dr. Keith Stewart from the Mayo Clinic summarized the latest findings from research related to the protein cereblon...
View ArticleBeacon NewsFlashes – April 15, 2013
Velcade-Thalidomide-Dexamethasone Combination May Be Effective After A Stem Cell Transplant In Multiple Myeloma Patients – Results from a French study show that the combination of Velcade (bortezomib),...
View ArticleTwo New Studies Investigate The Significance Of Minimal Residual Disease In...
The results of two recent European studies provide new insights into minimal residual disease detection and its potential value in the treatment of multiple myeloma. The first study, carried out in...
View ArticleBeacon NewsFlashes – July 3, 2013
Hybrid Drugs Based On Thalidomide And Curcumin May Be A Future Treatment Option For Myeloma Patients – Results from a recent preclinical study indicate that hybrid molecules combining chemical...
View ArticleAspirin Not As Effective As Other Agents In Preventing Blood Clots During...
Results from a recent French study based on data from clinical practice indicate that vitamin K antagonists and low-molecular weight heparin are more effective than aspirin in preventing clots during...
View Article
